Biotech

All Articles

Praxis epilepsy drug minimizes confiscations in period 2 trial

.Practice Precision Medicines has actually racked up one more midphase gain in epilepsy this year, w...

Three directors surrender as Dyne blog posts combined information for DMD prospect

.After leaving a scientific hold a number of years back, Dyne Therapy has actually revealed brand-ne...

Arrowhead fires off phase 3 data in uncommon metabolic illness before market encounter Ionis

.Arrowhead Pharmaceuticals has actually shown its hand ahead of a possible face-off with Ionis, publ...

Pfizer, Valneva show lyme condition go efficient for 2nd enhancer

.Pfizer and Valneva may possess concerning pair of even more years to hang around just before they c...

Fierce Biotech Managing Editor Ayla Ellison Speaks Shop with Michelle Benz on the Future of Biotech.

.Allow's study a conversation along with Ayla Ellison, Ferocious Biotech Managing Editor and Michell...

New information show how Bayer's asundexian failed to avoid strokes

.Bayer suspended the stage 3 test for its aspect XIa inhibitor asundexian late last year after the m...

Sanofi's tolebrutinib fails 2 of 3 late-stage MS tests

.Sanofi is actually still set on taking its own multiple sclerosis (MS) med tolebrutinib to the FDA,...

Galapagos' stockpile as fund shows intent to form its own development

.Galapagos is actually coming under added pressure from entrepreneurs. Having actually developed a 9...

Cell- concentrated Sana scoops very first CSO-- Chutes &amp Ladders

.Welcome to this week's Chutes &amp Ladders, our roundup of substantial management hirings, firings ...

Allist settles Jacobio $21M, landing function in Chinese KRAS race

.Shanghai Allist Pharmaceuticals has gotten itself a starring character in China's KRAS market, payi...